These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8751016)

  • 21. Captopril does not improve insulin action in essential hypertension: a double-blind placebo-controlled study.
    Wiggam MI; Hunter SJ; Atkinson AB; Ennis CN; Henry JS; Browne JN; Sheridan B; Bell PM
    J Hypertens; 1998 Nov; 16(11):1651-7. PubMed ID: 9856366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of aqueous extract of Hibiscus sabdariffa on the renin-angiotensin-aldosterone system of Nigerians with mild to moderate essential hypertension: A comparative study with lisinopril.
    Nwachukwu DC; Aneke EI; Obika LF; Nwachukwu NZ
    Indian J Pharmacol; 2015; 47(5):540-5. PubMed ID: 26600645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose and lipid metabolism in essential hypertension: effects of diuretics and ACE-inhibitors.
    De Cesaris R; Ranieri G; Filitti V; Andriani A; Lamontanara G
    Cardiology; 1993; 83(3):165-72. PubMed ID: 8281530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.
    Fogari R; Zoppi A; Preti P; Fogari E; Malamani G; Mugellini A
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):921-6. PubMed ID: 11587159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postsynaptic alpha 1-blockade with terazosin does not modify insulin sensitivity in nonobese normotensive subjects.
    Ferrari P; Rosman J; Neuner N; Shaw S; Riesen W; Weidmann P
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):106-10. PubMed ID: 1719277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Control of hyperinsulinemia in essential hypertension using the angiotensin-converting enzyme inhibitor, lisinopril].
    Umnerová V; Jarolím M; Jindra A; Jáchymová M; Peleska J; Savlíková J; Stolba P; Horký K
    Cor Vasa; 1993; 35(2):75-9. PubMed ID: 8388786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four week administration of an ACE inhibitor and a cardioselective beta-blocker in healthy volunteers: no influence on insulin sensitivity.
    Heinemann L; Heise T; Ampudia J; Sawicki P; Sindelka G; Brunner G; Starke AA
    Eur J Clin Invest; 1995 Aug; 25(8):595-600. PubMed ID: 7589016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twenty-four hour blood pressure effect of once-daily lisinopril, enalapril, and placebo in patients with mild to moderate hypertension.
    Whelton A; Dunne B; Glazer N; Kostis JB; Miller WE; Rector DJ; Tresznewsky ON
    J Hum Hypertens; 1992 Aug; 6(4):325-31. PubMed ID: 1331444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia.
    Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G
    Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of effects of combined ACE inhibitor and low-dose thiazide diuretic with ACE inhibitor alone on insulin action in patients with hypertension and Type 2 diabetes: a double-blind crossover study.
    McLaughlin DM; Atkinson AB; Ennis CN; Browne J; Hunter SJ; Sheridan B; Bell PM
    Diabet Med; 2008 May; 25(5):631-4. PubMed ID: 18445178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients.
    Taddei S; Omboni S; Ghiadoni L; Caiazza A; Fogari R; Innocenti P; Porcellati C; Giovannetti R; Corradi L; Mancia G; Salvetti A
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):579-85. PubMed ID: 12658059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.
    Santoro D; Natali A; Palombo C; Brandi LS; Piatti M; Ghione S; Ferrannini E
    Hypertension; 1992 Aug; 20(2):181-91. PubMed ID: 1639459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of lisinopril and hydrochlorothiazide on platelet function and blood rheology in essential hypertension: a randomly allocated double-blind study.
    Zannad F; Bray-Desboscs L; el Ghawi R; Donner M; Thibout E; Stoltz JF
    J Hypertens; 1993 May; 11(5):559-64. PubMed ID: 8390528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients.
    Fogari R; Zoppi A; Lazzari P; Preti P; Mugellini A; Corradi L; Lusardi P
    J Cardiovasc Pharmacol; 1998 Oct; 32(4):616-20. PubMed ID: 9781930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Smidt UM; Chen JW; Sato A; Parving HH
    Scand J Clin Lab Invest; 1997 Aug; 57(5):427-34. PubMed ID: 9279969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parameters.
    Zehetgruber M; Beckmann R; Gabriel H; Christ G; Binder BR; Huber K
    Thromb Res; 1996 Jul; 83(2):143-52. PubMed ID: 8837313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lisinopril and bisoprolol on lipoprotein metabolism in patients with mild-to-moderate essential hypertension.
    Saku K; Liu K; Takeda Y; Jimi S; Arakawa K
    Clin Ther; 1995; 17(6):1136-46. PubMed ID: 8750405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.